awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33704088-99BAEC96-C415-4064-8A1F-96BA832FEF66
Q33704088-99BAEC96-C415-4064-8A1F-96BA832FEF66
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33704088-99BAEC96-C415-4064-8A1F-96BA832FEF66
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib.
P2860
Q33704088-99BAEC96-C415-4064-8A1F-96BA832FEF66
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33704088-99BAEC96-C415-4064-8A1F-96BA832FEF66
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e01e10239db82b51f153211ea9f5bc05191bb64a
P2860
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.